Nuvalent Inc (NUVL)

87.42 +0.56 (+0.64%) USD  |  NASDAQ  |  Dec 16, 16:00
88.69 +1.27 (+1.45%) After-Hours: 05:34
More

Nuvalent Max Drawdown (5Y)

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for NUVL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cumulative Total Returns Versus Peers
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Viking Therapeutics Inc 89.26%
Bristol-Myers Squibb Co 47.67%
Replimune Group Inc 90.48%
Moderna Inc 92.39%
NovaBay Pharmaceuticals Inc 99.98%